Clinical Trials Logo

Filter by:
NCT ID: NCT04153617 Completed - Clinical trials for Overweight and Obesity

Enriched Honey With Soluble Fiber and Polyphenols on Satiety and Dyslipidemia

SACIMIEL
Start date: January 14, 2019
Phase: N/A
Study type: Interventional

The aim of this trial is to evaluate the possible benefits on saciety and dyslipidemia in subjects with overweight/obesity (BMI ≥25 y <40 kg / m2) and dyslipemia after consumption of a modifed honey with soluble fiber and polyphenols. Some studies have shown the contribution of high-fiber foods in the reduction of the cardiovascular risk. Besides, polyphenols have reported with their potent antioxidant effect and their implication lowering the vardiovascular risk.

NCT ID: NCT04153500 Completed - Pelvic Floor Clinical Trials

Validation of a Female Pelvic Floor Interactive Training Model

Start date: November 25, 2019
Phase: N/A
Study type: Interventional

Residents increase their knowledge of female pelvis anatomy using a pelvic floor interactive model methodology (Pelvic+) compared to the traditional methodology.

NCT ID: NCT04153305 Completed - Myelofibrosis Clinical Trials

European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study

ERNEST
Start date: October 8, 2019
Phase:
Study type: Observational

The Fondazione per la Ricerca Ospedale di Bergamo (FROM) decided to propose and promote the completion of ERNEST registry: the aim of the project is to obtain up-to-date estimates of clinical outcome of these patients in primary and secondary Myelofibrosis that have been included in the 'original' ERNEST study. The last was conducted between 2012 and beginning of 2015 including 1292 patients with Myelofibrosis, but it was interrupted in 2015 because of bankruptcy of the previous sponsor.

NCT ID: NCT04152070 Completed - Frailty Clinical Trials

Spanish-language Version of the Kihon Checklist

Start date: March 1, 2018
Phase:
Study type: Observational

The purpose of this cross-sectional study is to validate the Spanish version of the Kihon Checklist for screening frailty in Spanish community-dwelling older adults.

NCT ID: NCT04151641 Completed - Clinical trials for Dietary Modification

Mangoselect®: Characterization, Pharmacokinetics and Bioavailability of Xanthone Metabolites

Start date: November 11, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to compare pharmacokinetics and bioavailability of phenolic compounds, mainly xanthones, from a mangosteen extract, either ingested in a dry powder form or in an encapsulated form. Absorption and metabolism will be determined by measuring urinary excretion of phenolic metabolites and blood metabolic profile over 72 hours by means of High Pressure Liquid Chromatography (HPLC) coupled with tandem mass spectroscopy. The design of this study is a cross-over, double-blind and randomized trial on 10 healthy subjects.

NCT ID: NCT04151394 Completed - Clinical trials for Surgery--Complications

Side-to-side Duodenojejunostomy After Distal Duodenal Resection (DUORESECT)

DUORESECT
Start date: January 31, 2019
Phase:
Study type: Observational [Patient Registry]

Lower partial duodenectomy could be indicated in case of injury, wide neck diverticulum, tumor invasion by other tumors such as retroperitoneal sarcoma and primary tumor of 3rd and 4th portion of the duodenum. Reconstruction after resection is usually performed by a end-to-end or end-to-side anastomosis. The investigators analyze the short and long-term results of a case series with resection for various lesions in the third and fourth duodenal portions and reconstruction of the intestinal transit through side-to-side duodenojejunostomy

NCT ID: NCT04150952 Completed - Emotions Clinical Trials

HRV-based Training Effects in Athletes

HRV-btA
Start date: September 7, 2019
Phase: N/A
Study type: Interventional

Monitoring individual responses to training is an important key factor to prescribe to most effective training programs. Heart-rate variability (HRV) could be used for monitoring the training status of endurance athletes in order to detect the fatigue status and to assess the adaptation to training. This direct fatigue measuring method has been little used to prescribe or regulate exercise prescription. Moreover, it allows new possibilities for the training load prescription according to an athlete's status, the response to the training load, and the adaptation to training. Regardless HRV-guided training, the athlete performance could also be influenced by precompetitive mood and anxiety, which can also be reflected in the precompetitive HRV scores and the subjective effort perception.

NCT ID: NCT04150328 Completed - Clinical trials for Diffuse Large B Cell Lymphoma

Lenalidomide Monotherapy in R/R DLBCL

RE-MIND
Start date: April 12, 2019
Phase:
Study type: Observational

This observational study is designed to characterise the effectiveness of lenalidomide monotherapy in the treatment of R/R DLBCL and to compare the results with the efficacy outcomes of a tafasitamab-lenalidomide combination therapy in the clinical trial MOR208C203 (L-MIND)

NCT ID: NCT04150211 Completed - Joint Pain Clinical Trials

Effects of Exten(d) Supplementation on Training Ability in Recreational Runners

Exten(d)
Start date: September 10, 2018
Phase: Phase 2
Study type: Interventional

The study will assess running biomechanics and joint inflammation of physically active males between 40 and 60 years of age, mainly runners, suffering from knee joint inflammation and pain after training. Participants were split into two groups, intervention and placebo, to evaluate the safety and efficacy of Exten(d) supplementation during 4 weeks.

NCT ID: NCT04149171 Completed - Hemorrhagic Shock Clinical Trials

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage

Start date: September 26, 2018
Phase: Phase 3
Study type: Interventional

Study Design: Single-center, not-randomized, open-label, two-arms controlled pilot clinical trial. Health Condition: Patients with severe trauma with a need for transfusion and categorized as priority 0 or 1 according to the Catalan Health Service (CatSalut) Polytrauma Code (PPT)